CVRx (CVRX) Treasury Shares (2020 - 2026)

CVRx's (CVRX) quarterly Treasury Shares came in at $922298.0 in Q1 2026, up 176.03% year-on-year from $334128.0 in Q1 2025, and up 140.64% quarter-over-quarter from $383268.0 in Q4 2025.

CVRx (CVRX) Treasury Shares (2020 - 2026) Analysis & Trends

CVRx's Treasury Shares history runs 4 years deep, the most recent figure standing at $922298.0 for Q1 2026.

  • On a quarterly basis, Treasury Shares rose 176.03% year-over-year to $922298.0 in Q1 2026; TTM through Mar 2026 was $922298.0, a 176.03% increase from a year earlier, with the FY2025 full-year figure at $383268.0, changed N/A from the prior year.
  • Treasury Shares climbed to $922298.0 in Q1 2026 per CVRX's latest filing, from $383268.0 in the prior quarter.
  • Across five years, Treasury Shares topped out at $922298.0 in Q1 2026 and bottomed at $334128.0 in Q1 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Treasury Shares (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn 16.94 Bn
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn -
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn 7.70 Mn
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn 263.29 Mn
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn 83.00 Mn
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn 2.12 Bn
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn 14.05 Mn
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn 4.51 Mn
9 Smith & Nephew 25.80 Bn 25.22 Bn - 515.00 Mn
10 CVRx 128.88 Mn 56.58 Mn 12.88 Mn 922,298.00

Historic Data

Download Data
DateValue
Mar 31, 2026 922,298.00
Mar 31, 2026 922,298.00
Dec 31, 2025 383,268.00
Dec 31, 2025 383,268.00
Sep 30, 2025 351,638.00
Sep 30, 2025 351,638.00
Jun 30, 2025 335,658.00
Jun 30, 2025 335,658.00
Mar 31, 2025 334,128.00
Mar 31, 2025 334,128.00
Jun 30, 2021 223.54 Mn
Jun 30, 2021 223.54 Mn
Mar 31, 2021 223.54 Mn
Mar 31, 2021 223.54 Mn
Dec 31, 2020 223.54 Mn
Dec 31, 2020 223.54 Mn
Sep 30, 2020 223.54 Mn
Sep 30, 2020 223.54 Mn
Jun 30, 2020 161.04 Mn
Jun 30, 2020 161.04 Mn